Jasper Ridge Partners, L.P. Alector, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $4.43 Billion
- Q3 2025
A detailed history of Jasper Ridge Partners, L.P. transactions in Alector, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 71,776 shares of ALEC stock, worth $89,002. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,776
Previous 30,632
134.32%
Holding current value
$89,002
Previous $42,000
404.76%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALEC
# of Institutions
158Shares Held
58MCall Options Held
614KPut Options Held
223K-
Black Rock Inc. New York, NY9.1MShares$11.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.99MShares$8.67 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.03MShares$7.48 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$2.94 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$2.71 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $102M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...